New CEO has work cut out as AstraZeneca sales fall

Your Health Matters

Handout photograph of AstraZeneca Chief Executive Pascal SoriotLONDON (Reuters) – AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent expiries on once best-selling medicines and a thin pipeline of new drugs, the former Roche executive, who joined on October 1, needs to re-focus operations and step up the hunt for acquisitions, analysts believe. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave